The AHA today urged the Health and Human Services Secretary to extend the public health emergency beyond its current July 25, 2020 expiration date so “health care providers can continue to offer the most efficient and effective care possible during the continuing COVID-19 pandemic.”

HHS Secretary Azar Jan. 31 declared a public health emergency in response to the COVID-19 pandemic.

“The challenges that our members have faced — rapid bed capacity increases, overnight telehealth system overhauls and implementation, and personal protective equipment acquisition — have been nothing short of extraordinary,” AHA said. “However, with your help, hospitals and health systems, have used every tool at their disposal to respond to this unprecedented challenge. Without your action and the impact of the public health declaration, these challenges would have been exponentially more difficult to overcome, which is why we are asking for continued action from HHS moving forward. We anticipate the challenges associated with COVID-19 that our members and communities face every day will continue throughout several months, and potentially another entire year if we continue to experience increased COVID-19 cases.”

AHA said the public health emergency should be extended until a number of criteria are met.

See the AHA letter for more details.

Related News Articles

Headline
A new AHA podcast explores how rural hospitals have found new ways to deliver care to patients with COVID-19. Brian Evans, CEO of Clarke County Hospital in…
Headline
Certain groups of workers showed significantly more absenteeism in March and April 2020, suggesting a link to COVID-19 exposure, according to a new study…
Headline
The Department of Health and Human Services today announced that it will distribute over $4 billion in additional funds from the Public Health and Social…
Perspective
Wear a mask. Wash your hands. Keep your distance. These are three simple actions we know that will stop the spread of COVID-19. The AHA, American Medical…
Headline
The Mount Sinai Health System will partner with Emergent BioSolutions and ImmunoTek Bio Centers on the development and evaluation of a COVID-19 hyperimmune…
Headline
Gilead Sciences yesterday said it is starting phase one clinical study of inhaled remdesivir for potential outpatient treatment of COVID-19. In a statement,…